MLTX NASDAQ
MoonLake Immunotherapeutics
1W: -6.7%
1M: -6.0%
3M: +11.0%
YTD: +56.6%
1Y: -66.0%
3Y: -67.0%
5Y: +84.3%
$18.71
-1.17 (-5.89%)
Weekly Expected Move ±6.7%
$16
$18
$19
$20
$22
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.5B
52W Range5.95-62.75
Volume990,096
Avg Volume1,113,740
Beta1.04
Dividend—
Analyst Ratings
Company Info
CEOJorge Santos da Silva
Employees130
SectorHealthcare
IndustryBiotechnology
IPO Date2020-10-20
Websitemoonlaketx.com
Dorfstrasse 29
Zug, ZG 6300
CH
Zug, ZG 6300
CH
41 415108022
About MoonLake Immunotherapeutics
MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancement of Sonelokimab, an innovative, investigational Nanobody-based treatment engineered to target inflammatory conditions. Currently, Sonelokimab is undergoing mid-stage (Phase II) clinical trials for a range of inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and both ankylosing spondylitis and radiographic axial spondyloarthritis. Established in 2021, MoonLake Immunotherapeutics is based in Zug, Switzerland.
Latest News
MoonLake Immunotherapeutics' CFO Sells 39K Shares
MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa
Why MoonLake Immunotherapeutics Stock Wilted on Wednesday
MoonLake Immunotherapeutics prices $200M public offering of Class A shares
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Reich Kristian | S-Sale | 2,448 | $20.00 | 2026-07-22 |
| Reich Kristian | S-Sale | 50,000 | $20.02 | 2026-07-21 |
| Reich Kristian | S-Sale | 43,700 | $20.09 | 2026-07-20 |
| Reich Kristian | S-Sale | 16,105 | $20.01 | 2026-07-15 |
| Santos da Silva Jorg | S-Sale | 68,289 | $20.02 | 2026-07-10 |